James Hassard, Chief Commercial Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 7,250 shares at $89.22 ($647K) on 2021-06-22, disclosed to the SEC on 2021-06-24.
Open-market sale of $647k ARWR by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.22 | 3,625 | $323K | 50.0% |
| 2 | $89.22 | 3,625 | $323K | 50.0% |
| Total | $89.22 avg | 7,250 | $647K | 100% |
| Filing → |
| ARWR | SELL | 2021-01-08 | $1.2M | — | Filing → |